Stay updated with breaking news from 67000210. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reissued their buy rating on shares of Novavax (NASDAQ:NVAX – Free Report) in a research note published on Thursday morning, Benzinga reports. They currently have a $35.00 price objective on the biopharmaceutical company’s stock. Several other analysts have also recently commented on NVAX. B. Riley upgraded Novavax from a neutral rating to a […]
Novavax, Inc. (NASDAQ:NVAX – Free Report) – Equities research analysts at B. Riley lifted their Q4 2023 EPS estimates for Novavax in a research report issued to clients and investors on Wednesday, August 9th. B. Riley analyst M. Mamtani now expects that the biopharmaceutical company will earn $0.47 per share for the quarter, up from […]
Novavax, Inc. (NASDAQ:NVAX – Free Report) – Research analysts at B. Riley lifted their Q4 2023 EPS estimates for shares of Novavax in a report issued on Wednesday, August 9th. B. Riley analyst M. Mamtani now forecasts that the biopharmaceutical company will earn $0.47 per share for the quarter, up from their prior estimate of […]
Novavax, Inc. (NASDAQ:NVAX – Get Free Report)’s stock price rose 10% during mid-day trading on Thursday . The stock traded as high as $7.88 and last traded at $7.83. Approximately 3,244,466 shares traded hands during mid-day trading, a decline of 49% from the average daily volume of 6,367,392 shares. The stock had previously closed at […]
Novavax (NASDAQ:NVAX – Get Free Report) announced its earnings results on Tuesday. The biopharmaceutical company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of ($1.24) by $1.82, Briefing.com reports. The company had revenue of $424.40 million during the quarter, compared to the consensus estimate of $264.16 million. Novavax’s revenue for the quarter was […]